Ideas at Work: Feature

Want to Grow Your Retirement Savings? Then Forget About It.

Ideas at Work: Feature
October 23, 2014
New research shows that the less frequently investors check their portfolios, the better off they are.
Read article

To Reap Innovation’s Rewards, Team Up

Ideas at Work: Feature
July 23, 2014
Why does new technology spread so slowly in many industries?
Read article

What Makes an Idea Creative?

Ideas at Work: Feature
June 19, 2014
If you want your idea to be innovative, you need to hit the right mix of novelty and familiarity, a new study shows.
Read article

Option for Control

Ideas at Work: Feature
May 15, 2014
CEOs use their options to fight proxy battles.
Read article

Friendly Influence

Ideas at Work: Feature
May 15, 2014
A new study sheds light on how the structures of social networks help or hinder the spread ideas, fashion, and even social movements.
Read article

The Vikings Return to America

Ideas at Work: Feature
May 29, 2014

A new report on Norway’s pension fund points toward a Canadian model for active investment management.

Read article

Competing With Bias

Ideas at Work: Feature
April 3, 2014

Research shows how discrimination works in the hiring process and suggests that science and tech firms that leave it unaddressed may overlook talented female candidates.

Read article

Save or Be Selfish?

Ideas at Work: Feature
January 24, 2014
A new model can help economists understand how spouses make financial decisions — and why many couples struggle to save.
Read article

In Urban Markets, Real Estate Opportunities are Unprecedented

Ideas at Work: Feature
May 9, 2016
Lynne Sagalyn, Earle W. Kazis and Benjamin Schore Professor of Real Estate, discusses the ever-changing nature of the real estate business, and New York’s prominence on the global stage.
Read article

Even at Current Prices, Drug Innovation is a Cost-Effective Means to Curb Cancer

Ideas at Work: Feature
Conrad de Aenlle |  April 28, 2016
The pharmaceuticals industry has attracted heightened scrutiny from the media and politicians in the aftermath of a well-publicized scandal. But new evidence suggests that, for now at least, the cost of pharmaceutical innovation is well worth it.
Read article

Pages